LTFS
ELV icon

Ladenburg Thalmann Financial Services’s Elevance Health ELV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3.42M Sell
15,232
-694
-4% -$191K 0.02% 632
2019
Q3 		$3.82M Buy
15,926
+1,788
+13% +$490K 0.03% 560
2019
Q2 		$3.99M Sell
14,138
-612
-4% -$167K 0.03% 526
2019
Q1 		$4.24M Buy
14,750
+2,491
+20% +$720K 0.03% 484
2018
Q4 		$3.2M Buy
12,259
+2,919
+31% +$803K 0.03% 509
2018
Q3 		$2.56M Sell
9,340
-736
-7% -$191K 0.02% 623
2018
Q2 		$2.21M Hold
10,076
– – 0.02% 656
2018
Q1 		$2.21M Buy
10,076
+1,625
+19% +$382K 0.02% 656
2017
Q4 		$1.9M Buy
8,451
+232
+3% +$49.4K 0.02% 715
2017
Q3 		$1.56M Buy
8,219
+1,109
+16% +$211K 0.02% 746
2017
Q2 		$1.34M Buy
7,110
+23
+0.3% +$4.13K 0.02% 786
2017
Q1 		$1.17M Sell
7,087
-238
-3% -$37.9K 0.01% 812
2016
Q4 		$1.05M Sell
7,325
-463
-6% -$62K 0.01% 825
2016
Q3 		$973K Sell
7,788
-1,667
-18% -$215K 0.01% 812
2016
Q2 		$1.24M Sell
9,455
-2,307
-20% -$316K 0.02% 657
2016
Q1 		$1.64M Buy
11,762
+1,399
+13% +$187K 0.03% 497
2015
Q4 		$1.45M Sell
10,363
-439
-4% -$60.5K 0.03% 517
2015
Q3 		$1.51M Sell
10,802
-6,461
-37% -$971K 0.03% 473
2015
Q2 		$2.86M Buy
17,263
+6,694
+63% +$1.07M 0.05% 338
2015
Q1 		$1.63M Buy
10,569
+2,346
+29% +$334K 0.03% 482
2014
Q4 		$1.04M Buy
8,223
+512
+7% +$63.3K 0.02% 583
2014
Q3 		$922K Buy
7,711
+341
+5% +$39.1K 0.03% 535
2014
Q2 		$793K Buy
7,370
+330
+5% +$34K 0.02% 581
2014
Q1 		$701K Buy
7,040
+568
+9% +$51.4K 0.02% 599
2013
Q4 		$596K Buy
6,472
+766
+13% +$68.1K 0.02% 636
2013
Q3 		$480K Buy
5,706
+323
+6% +$27.7K 0.02% 678
2013
Q2 		$442K Buy
+5,383
New +$403K 0.02% 675

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ELV Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Elevance Health (ELV) stake by 4.4% in Q4 2019, selling an estimated $191K and leaving 15,232 shares worth $3.42M. The position accounts for 0.02% of the portfolio, ranked #632.

Ladenburg Thalmann Financial Services first reported a position in ELV in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.24M in Q1 2019. 1,112 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 15,232 shares of Elevance Health worth $3.42M as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 694 Elevance Health shares in Q4 2019, an estimated $191K.
  • Elevance Health made up 0.02% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #632 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Elevance Health in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Elevance Health position peaked at $4.24M in Q1 2019.
  • 1,112 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.